{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}]}],"denomUnitsSelected":"sentinel lymph nodes (SLNs)","denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"11"}],"units":"sentinel lymph nodes (SLNs)"}],"description":"The presence or absence of metastatic deposits in SLNs will be obtained by pathology (when available).","groups":[{"description":"Patients receive perflubutane microbubble injections subdermally and then undergo ultrasound over 30 minutes before standard of care cancer treatment.\n\nPerflubutane Microbubble: Given subdermally\n\nContrast-Enhanced Ultrasound: Undergo ultrasound","id":"OG000","title":"Diagnostic (Perflubutane Microbubble, Ultrasound)"}],"paramType":"NUMBER","populationDescription":"Only participants who completed CEUS and surgery (N=5) were analyzed.","reportingStatus":"POSTED","timeFrame":"Within 7 days post-surgery","title":"Presence of Metastatic Deposits in the Sentinel Lymph Node (SLNs)","type":"SECONDARY","typeUnitsAnalyzed":"sentinel lymph nodes (SLNs)","unitOfMeasure":"Metastatic sentinel lymph nodes (SLNs)"}